May 19, 2020
The Office of the Vice President for Research (OVPR) developed this weekly e-newsletter to share important news, resources and funding opportunities related to COVID-19.

Research to begin gradual restart

After a May 15 executive order from Governor Gretchen Whitmer, Vice President for Research Rebecca Cunningham announced plans for a phased re-engagement of U-M research.

Laboratory and studio activity will resume gradually and carefully in coming weeks. Six schools and colleges will lead the first wave, including LSA, Engineering, the Medical School, Architecture and Urban Planning, Pharmacy, and the Life Sciences Institute. These units will oversee the opening of eight campus buildings, with a single work shift, limited capacity and strict safety measures in place.

This pilot phase will allow research leadership to assess performance metrics for safety, health and compliance with state guidelines. They will evaluate what works well and what practices may need improvement before a more expansive second wave.

Unit leaders have developed specific plans for building access and approval of individual lab safety plans. Researchers are encouraged to work closely with their leadership on lab approvals and completing necessary training requirements before returning to work onsite.

Researchers in other buildings who were previously approved to access labs for essential activities may continue to do so.

More details available on UMOR's COVID-19 Research Portal:  

Research security during the pandemic

The following message was relayed to UMOR from the Michigan office of the FBI: 

“During the ongoing national health emergency, the FBI encourages research institutions and investigators to remain vigilant for any attempts by organizations or individuals, whether foreign or domestic, to unlawfully obtain and or remove sensitive research, including but not limited to research related to COVID-19, and including that funded by the U.S. Government. The FBI also encourages these same entities to proactively review existing safeguards, including cyber security, in order to ensure this research remains protected.”

For further guidance, or to report any unusual or suspicious activity associated with research security, please contact the U-M Division of Public Safety and Security through their non-emergency channels, (734) 763-1131 or

With many researchers working from home, this also is an opportunity to review safe computing practices at U-M. Check out the U-M safecomputing website; the sensitive data guide on that site is designed to help you make informed decisions about how to safely store and share university data. You may report an IT security incident at

MIDAS announces COVID-19 grantees

The Michigan Institute for Data Science (MIDAS) funded seven interdisciplinary teams to pursue COVID-19-related research projects. With data science methods at the core, these teams will combat the pandemic in varied and creative ways, including seeking better clinical decisions for in-patients, improving testing, addressing health disparities, using data-driven guidance to inform social distancing and reopening, and detecting spread in high-risk communities.

Read the full announcement

Evidence discovery platform for COVID-19 studies

Causaly is providing free, temporary trial access to its evidence discovery platform through the end of June for use in COVID-19 related research. The platform uses natural language processing to identify and visualize causal statements from PubMed, Scopus, and 40,000+ full-text papers comprising the Covid-19 Open Research Dataset (CORD-19). Interested researchers may contact Tyler Nix ( at the Taubman Health Sciences Library for a trial link or more information.

Internal funding to support COVID-19 research

COVID-19 Research Index

U-M researchers across a variety of disciplines are using their expertise to address the global COVID-19 pandemic. In an effort to increase awareness and foster collaboration among U-M researchers studying the novel coronavirus, OVPR created a COVID-19 Research Index that lists more than 150 projects in all stages of development — from planning to fully launched.

Access the research index

Index your COVID-19 research

RD support to help mobilize research teams

UMOR's Research Development team offers funding consultations and proposal development services for pulling together external applications, as well as virtual facilitation services for ideation sessions or project planning. The team can help you brainstorm with old and new collaborators, hone research questions, generate specific aims and develop plans for propelling the project forward.

Contact Jill Jividen, Director of Research Development, for more information (, or 803-429-6320).


Funding opportunities to support COVID-19 research are available at the link below:

Newest External Funding Opportunities

SAMHSA: COVID-19 Emergency Response for Suicide Prevention Grants

Full Application Deadline
May 22, 2020
PCORI: COVID-19 Targeted PFA Full Application Deadline
May 26, 2020
AHRQ: Novel, High-Impact Studies Evaluating Health System and Healthcare Professional Responsiveness to COVID-19 (R01) Full Application Deadline June 15, 2020
Dept. of State: Countering Corruption amid COVID-19 Full Application Deadline June 12, 2020
EPA: State Environmental Justice Cooperative Agreement Program (SEJCA)/COVID-19 Projects Full Application Deadline June 30, 2020
WELLtech1: Call for Wellness Technology Startups Full Application Deadline May 21, 2020
CEPI: Achieving an unprecedented acceleration of vaccine development and global manufacturing capacity to prevent COVID-19 Full Application Deadline Rolling, until June 30, 2020

American Diabetes Association: COVID-19 and Diabetes Research Award
Full Application Deadline May 22, 2020
IMLS: CARES Act Grants for Museums and Libraries
Full Application Deadline
June 12, 2020



A comprehensive list of U-M publications related to COVID-19 research is available here. The following have been published since April 30, 2020:
Daou, B. J., Koduri, S., Palmateer, G., Thompson, B. G., Chaudhary, N., Gemmete, J. J., & Pandey, A. S. (2020). Letter: Neurological Implications of COVID-19 and Lessons Learned From Prior Epidemics and PandemicsNeurosurgery, nyaa186.

Farkash, E. A., Wilson, A. M., & Jentzen, J. M. (2020). Ultrastructural Evidence for Direct Renal Infection with SARS-CoV-2. Journal of the American Society of Nephrology, ASN.2020040432.

Laventhal, N., Basak, R., Dell, M. L., Diekema, D., Elster, N., Geis, G., … Macauley, R. (2020). The Ethics of Creating a Resource Allocation Strategy During the COVID-19 Pandemic. Pediatrics, e20201243.

Operario, D., King, E. J., & Gamarel, K. E. (2020). Prioritizing Community Partners and Community HIV Workers in the COVID-19 Pandemic. AIDS and Behavior, s10461-020-02896–0.

Rosemberg, M.-A. S. (2020). Health and safety considerations for hotel cleaners during Covid-19Occupational Medicine, kqaa053.

Standiford, T., Shuman, A. G., Fessell, D., Brenner, M. J., & Bradford, C. R. (2020). Upholding the Tripartite Mission in Times of Crisis: Purpose and Perseverance in the COVID-19 Pandemic. Otolaryngology–Head and Neck Surgery, 019459982092298.

Welling, P. A., Batlle, D., Byrd, J. B., Burrell, L. M., South, A. M., & Sparks, M. A. (2020). Rigor before speculation in COVID-19 therapy. American Journal of Physiology-Lung Cellular and Molecular Physiology, 318(5), L1027–L1028.
© 2020 The Regents of the University of Michigan
The Office of the Vice President for Research (OVPR) developed this weekly e-newsletter to share important news, resources and funding opportunities related to COVID-19. If you have any further questions, please contact
U-M Office of the Vice President for Research | 503 Thompson St. | Ann Arbor, MI 48109